HIV Treatment Adds a Third One-a-Day Pill

Published April 1, 2014

HIV treatment adds a third one-a-day pill — Gilead Sciences’ one-pill-a-day HIV drug Quad is in the final phases of testing and could be approved by the FDA in August. If approved, Quad would become th…

WeHo pot convict not the first, but among the worst
Thousands, tens of thousands of people get surcease from a panoply of illnesses and side effects from treatment of illness through the use of medical marijuana. To many with cancer or AIDS, it is the only thing that stirs hunger enough to fuel feeble …
Read more on WeHo News

FDA Clears Meridians B. Pertussis Test
Meridian Bioscience, Inc. (VIVO – Snapshot Report) revealed that its new molecular diagnostic test for Bordetella pertussis has been cleared by U.S. Food and Drug Administration (FDA). It is the fifth assay on the company's illumigene platform and …
Read more on Zacks.com

Find More Drug Treatment News 2012 Information…